Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Thymopentin

DRUG

Stavudine

DRUG

Zidovudine

DRUG

Zalcitabine

DRUG

Didanosine

Trial Locations (50)

10001

Dr David DiPietro, New York

10010

Ctr for Special Immunology, New York

10014

Dr Howard A Grossman, New York

10016

Dr Patrick Hennessey, New York

10021

New York Hosp - Cornell Med Ctr, New York

10461

Van Etten Hosp / Bronx Municipal Hosp Ctr, The Bronx

15206

Novum Inc, Pittsburgh

19107

Philadelphia FIGHT, Philadelphia

19146

Graduate Hosp, Philadelphia

20003

Dr Larry Bruni, Washington D.C.

20037

Novum Inc, Washington D.C.

23666

Hampton Roads Med Specialists, Hampton

30327

West Paces Clinical Research Inc, Atlanta

33140

Stratogen of South Florida, Miami Beach

33146

Community Research Initiative, Coral Gables

33316

Ctr for Special Immunology, Fort Lauderdale

33334

Stratogen of Ft Lauderdale, Fort Lauderdale

33614

Infectious Disease Research Institute Inc, Tampa

Saint Joseph's Hosp / Infectious Disease Rsch Institute, Tampa

44106

Cleveland Clinic, Cleveland

46202

Infectious Diseases Research Clinic / Indiana Univ Hosp, Indianapolis

60611

Northwestern Univ Med Ctr, Chicago

60612

Rush Presbyterian - Saint Luke's Med Ctr, Chicago

60657

Ctr for Special Immunology, Chicago

63108

Systemic Mycoses Pathogen Study Group / Wash Univ Sch of Med, St Louis

67214

Univ of Kansas School of Medicine, Wichita

75219

Dr Christopher McNulty, Dallas

Nelson-Tebedo Community Clinic, Dallas

77006

Houston Clinical Research Network, Houston

78751

Central Texas Med Foundation, Austin

85013

Fisher Med Group, Phoenix

87108

Lovelace Scientific Resource, Albuquerque

90036

Beer Med Group, Los Angeles

90112

Gottlieb Med Group, Pasadena

90502

Harbor - UCLA Med Ctr, Torrance

91403

Pacific Oaks Med Group, Sherman Oaks

92102

HIV Research Group, San Diego

92718

Ctr for Special Immunology, Irvine

94063

AIDS Community Research Consortium, Redwood City

94115

Conant Med Group, San Francisco

Kaiser Permanente Med Ctr, San Francisco

97232

Dr Joel Godbey, Portland

98034

Novum Inc, Kirkland

117948153

SUNY / Health Sciences Ctr at Stony Brook, Stony Brook

641082792

Kansas City AIDS Research Consortium, Kansas City

741141325

Associates Med and Mental Health, Tulsa

06830

Dr Gary Blick, Greenwich

02445

CRI of New England, Brookline

00935

Univ of Puerto Rico Med Sciences Campus, Rio Piedras

00902

Initiativa Comunitaria de Investigacion, San Juan

All Listed Sponsors
lead

Immunobiology Research Institute

INDUSTRY

NCT00002109 - Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy | Biotech Hunter | Biotech Hunter